Short Interest in VanEck Biotech ETF (NASDAQ:BBH) Increases By 110.7%

VanEck Biotech ETF (NASDAQ:BBH) was the recipient of a large growth in short interest during the month of July. As of July 31st, there was short interest totaling 21,232 shares, a growth of 110.7% from the July 15th total of 10,079 shares. Currently, 1.1% of the shares of the stock are short sold. Based on an average daily trading volume, of 5,392 shares, the short-interest ratio is presently 3.9 days.

Insider Activity at VanEck Biotech ETF

In other news, major shareholder Sardar Biglari sold 6,533 shares of the firm’s stock in a transaction on Wednesday, July 15th. The shares were sold at an average price of $16.71, for a total transaction of $109,166.43. Following the sale, the insider owned 3,552,710 shares in the company, valued at approximately $59,365,784.10. This trade represents a 0.18% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Over the last 90 days, insiders have sold 10,493 shares of company stock valued at $175,335.

Institutional Investors Weigh In On VanEck Biotech ETF

Several hedge funds have recently added to or reduced their stakes in the company. Empowered Funds LLC purchased a new position in shares of VanEck Biotech ETF in the 4th quarter worth about $38,000. Allworth Financial LP raised its holdings in shares of VanEck Biotech ETF by 255.0% during the 4th quarter. Allworth Financial LP now owns 426 shares of the company’s stock valued at $81,000 after buying an additional 306 shares in the last quarter. Fifth Third Bancorp purchased a new position in shares of VanEck Biotech ETF during the 1st quarter valued at about $127,000. Huntington National Bank bought a new stake in VanEck Biotech ETF in the 4th quarter worth approximately $132,000. Finally, Evelyn Partners Asset Management Ltd lifted its position in VanEck Biotech ETF by 16.9% in the 4th quarter. Evelyn Partners Asset Management Ltd now owns 941 shares of the company’s stock worth $178,000 after buying an additional 136 shares during the last quarter. Institutional investors own 32.05% of the company’s stock.

VanEck Biotech ETF Stock Down 0.8%

NASDAQ:BBH traded down $1.72 during midday trading on Friday, hitting $217.92. The company had a trading volume of 3,436 shares, compared to its average volume of 5,691. VanEck Biotech ETF has a 52-week low of $160.91 and a 52-week high of $221.11. The stock’s fifty day moving average price is $202.89 and its 200-day moving average price is $194.35.

VanEck Biotech ETF Company Profile

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.